Table 1.
Total | SMAD4 staining (%)
|
||
---|---|---|---|
Positive | Negative | ||
Tumour site | |||
colonic tumours | 66 | 55 (83) | 11 (17) |
Right colon | 35 | 30 (86) | 5 (14) |
Splenic flexure | 2 | 1 (50) | 1 (50) |
Left colon | 29 | 24 (83) | 5 (17) |
Rectal tumours | 41 | 26 (63) | 15 (36)* |
Site unknown | 2 | 1 | 1 |
Total tumours | 109 | 82 (75) | 27 (25) |
TGFβR11 | |||
Frameshift mutation | 21 | 18 (86) | 3 (14) |
No mutations | 82 | 61 (74) | 21 (26) |
No data | 6 | 3 | 3 |
Total | 109 | 82 | 27 |
SMAD4 gene copy number | |||
Loss of copy number | 27 | 14 (51) | 13 (48) |
No change | 21 | 9 (42) | 12 (544) |
Gain of copy number | 4 | 4 (100) | 0 |
No data | 4 | 2 (50) | 2 (50) |
Total | 56 | 29 | 27 |
MSI | |||
MSI-High | 17 | 14 (82)* | 3 (18)‡ |
MSI-Low | 18 | 13 (72)† | 5 (28) |
MSS | 70 | 52 (74) | 18 (26) |
No data | 4 | ||
Total | 109 | 82 | 27 |
Loss of SMAD4 protein expression was more common in tumours diagnosed in the rectum than in the colon (P = 0.04).
Ten patients with early-onset colorectal cancer had germ-line mutations in MMR genes (8 in MLH1 and 2 in MSH2).
Four patients with early-onset colorectal cancer had germ-line mutations in MSH6.
All three patients with early-onset colorectal cancer had germ-line mutations in MMR genes (1 in MLH1 and 2 in MSH2).